Market Cap (In USD)
740.47 Thousand
Revenue (In USD)
324.23 Million
Net Income (In USD)
-83.06 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0098-0.0098
- PE
- -
- EPS
- -
- Beta Value
- 0.616
- ISIN
- US68236X1182
- CUSIP
- 68236X118
- CIK
- 1799191
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Dr. Daniel Virnich FACHE, M.B.A., M.D.
- Employee Count
- -
- Website
- -
- Ipo Date
- Details
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.
More Stocks
-
019680Daekyo Co., Ltd.
019680
-
ARES
-
RVLRaval ACS Ltd.
RVL
-
NRANRG Energy, Inc.
NRA
-
FNOXFortnox AB (publ)
FNOX
-
CGUIF
-
BERG-BBergman & Beving AB (publ)
BERG-B
-
TKNOAlpha Teknova, Inc.
TKNO